Clinical trial
Triptorelin for Ovary Protection in Childhood Onset Lupus
NCT00124514 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00124514 |
|---|---|
| Title | Triptorelin for Ovary Protection in Childhood Onset Lupus |
| Official title | Triptorelin for Ovary Protection in Childhood Onset Lupus |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | Watson Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug, Other |
| Interventions | Triptorelin pamoate, Triptorelin Pamoate, placebo |
| Enrollment | 31 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2014 |
| Completion | Mar 1, 2014 |
| First posted | Jul 28, 2005 |
| Last update posted | Jan 5, 2021 |
| Countries | Brazil, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: